Cargando…

Comparisons of Treatment for HER2-Positive Breast Cancer between Chinese and International Practice: A Nationwide Multicenter Epidemiological Study from China

OBJECTIVE: To better understand the status of medical treatment for human epidermal growth factor receptor 2 (HER2)-positive breast cancer and the differences between the Chinese and the international clinical practice. METHODS: This was a retrospective, nationwide, multicenter, epidemiological stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Yi-Qun, Yi, Zong-Bi, Yu, Pei, Wang, Wen-Na, Ouyang, Qu-Chang, Yan, Min, Wang, Xiao-Jia, Hu, Xi-Chun, Jiang, Ze-Fei, Huang, Tao, Tong, Zhong-Sheng, Wang, Shu-Sen, Yin, Yong-Mei, Li, Hui, Yang, Run-Xiang, Yang, Hua-Wei, Teng, Yue-E., Sun, Tao, Cai, Li, Li, Hong-Yuan, Ouyang, Xue-Nong, He, Jian-Jun, Liu, Xin-Lan, Yang, Shun-E., Qiao, You-Lin, Fan, Jin-Hu, Wang, Jia-Yu, Xu, Bing-He
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457988/ https://www.ncbi.nlm.nih.gov/pubmed/34567118 http://dx.doi.org/10.1155/2021/6621722

Ejemplares similares

Age at initial diagnosis and prognosis of breast cancer: a nationwide multicenter retrospective study in China
por: Yang, Huan, et al.
Publicado: (2022)

Molecular subtypes predict the preferential site of distant metastasis in advanced breast cancer: a nationwide retrospective study
por: Fan, Jin-Hu, et al.
Publicado: (2023)

Impact of dose-dense neoadjuvant chemotherapy on pathologic response and survival for HER2-positive breast cancer patients who receive trastuzumab
por: Wang, Lize, et al.
Publicado: (2021)

Reversibly immortalized hepatic progenitor cell line containing double suicide genes
por: Fang, Shu-Yu, et al.
Publicado: (2018)

HER2 somatic mutations are associated with poor survival in HER2‐negative breast cancers
por: Wang, Tonghui, et al.
Publicado: (2017)

Pyrotinib Treatment in Patients With HER2-positive Metastatic Breast Cancer and Brain Metastasis: Exploratory Final Analysis of Real-World, Multicenter Data
por: Anwar, Munawar, et al.
Publicado: (2021)

Therapeutic potential of HERS spheroids in tooth regeneration
por: Duan, Yufeng, et al.
Publicado: (2020)

Molecular landscape and efficacy of HER2-targeted therapy in patients with HER2-mutated metastatic breast cancer
por: Yi, Zongbi, et al.
Publicado: (2020)

A multicenter analysis of treatment patterns and clinical outcomes of subsequent therapies after progression on palbociclib in HR+/HER2− metastatic breast cancer
por: Li, Yi, et al.
Publicado: (2021)

Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients
por: Zhang, Shaohua, et al.
Publicado: (2016)

Clinical characteristics and effectiveness of antiviral agents in hospitalized children with infectious mononucleosis in China: A multicenter retrospective study
por: Hu, Huili, et al.
Publicado: (2021)

Genome Sequence of the Fish Pathogen Yersinia ruckeri SC09 Provides Insights into Niche Adaptation and Pathogenic Mechanism
por: Liu, Tao, et al.
Publicado: (2016)

Profile, treatment patterns, and influencing factors of anthracycline use in breast cancer patients in China: A nation‐wide multicenter study
por: Guo, Fengzhu, et al.
Publicado: (2021)

Efficacy of Neoadjuvant Single or Dual Anti-HER-2 Therapy Combined with Chemotherapy in Patients with HER-2-Positive Breast Cancer: A Single-Center Retrospective Study
por: He, Qian, et al.
Publicado: (2021)

Exploring the clinical outcomes and safety profile of inetetamab treatment in metastatic breast cancer patients: A multicenter assessment of a Chinese-origin recombinant Anti-HER2 monoclonal antibody
por: Liu, Binliang, et al.
Publicado: (2023)

Protection Effect of Curcumin for Macrophage-Involved Polyethylene Wear Particle-Induced Inflammatory Osteolysis by Increasing the Cholesterol Efflux
por: Liu, Yu-wei, et al.
Publicado: (2019)

Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: A Nation-Wide Multicenter Epidemiological Study in China
por: Wu, Yun, et al.
Publicado: (2021)

Risk Factors for Breast Cancer Among Chinese Women: A 10-Year Nationwide Multicenter Cross-Sectional Study
por: Lee, Hui, et al.
Publicado: (2014)

Circulating tumor DNA profile and its clinical significance in patients with hormone receptor-positive and HER2-negative mBC
por: Tang, Yu, et al.
Publicado: (2022)

Pyrotinib plus capecitabine for trastuzumab-resistant, HER2-positive advanced breast cancer (PICTURE): a single-arm, multicenter phase 2 trial
por: Cao, Jun, et al.
Publicado: (2023)

Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial
por: Yang, Yang, et al.
Publicado: (2023)

Identifying HER2 Inhibitors from Natural Products Database
por: Yang, Shun-Chieh, et al.
Publicado: (2011)

Structure-based discovery of neoandrographolide as a novel inhibitor of Rab5 to suppress cancer growth
por: Zhang, Jing, et al.
Publicado: (2020)

Assessing early changes in plasma HER2 levels is useful for predicting therapeutic response in advanced breast cancer: A multicenter, prospective, noninterventional clinical study
por: Kang, Yi‐Kun, et al.
Publicado: (2022)

Molecular features and clinical implications of the heterogeneity in Chinese patients with HER2-low breast cancer
por: Dai, Lei-Jie, et al.
Publicado: (2023)

Developing and validating a mortality prediction model for ICH in ITP: a nationwide representative multicenter study
por: Chong, Shan, et al.
Publicado: (2022)

Machine Learning Models to Improve the Differentiation Between Benign and Malignant Breast Lesions on Ultrasound: A Multicenter External Validation Study
por: Huo, Ling, et al.
Publicado: (2021)

Author Correction: Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial
por: Yang, Yang, et al.
Publicado: (2023)

Hepatoprotective potential of isoquercitrin against type 2 diabetes-induced hepatic injury in rats
por: Huang, Xiao-Li, et al.
Publicado: (2017)

Irisin Improves Autophagy of Aged Hepatocytes via Increasing Telomerase Activity in Liver Injury
por: Bi, Jianbin, et al.
Publicado: (2020)

METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2—breast cancer
por: Ouyang, Dengjie, et al.
Publicado: (2023)

The Role of HER2 in Self-Renewal, Invasion, and Tumorigenicity of Gastric Cancer Stem Cells
por: Sun, Li-Fei, et al.
Publicado: (2020)

N-linoleyltyrosine resisted the growth of non-small cell lung cancer cells via the regulation of CB(1) and CB(2) involvement of PI3K and ERK pathways
por: Hu, Yan, et al.
Publicado: (2023)

A comprehensive review on microbial production of 1,2-propanediol: micro-organisms, metabolic pathways, and metabolic engineering
por: Tao, Yuan-ming, et al.
Publicado: (2021)

Fusion of apoptosis‐related protein Cytochrome c with anti‐HER‐2 single‐chain antibody targets the suppression of HER‐2+ breast cancer
por: Lu, DanDan, et al.
Publicado: (2021)

Clinical Profile and Prognosis of Hereditary Transthyretin Amyloid Cardiomyopathy: A Single-Center Study in South China
por: Wang, Shuai, et al.
Publicado: (2022)

Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis
por: Chen, Qitong, et al.
Publicado: (2020)

Preoperative inflammatory markers of NLR and PLR as indicators of poor prognosis in resectable HCC
por: Wang, Dong, et al.
Publicado: (2019)

A nomogram for predicting the HER2 status in female patients with breast cancer in China: a nationwide, multicenter, 10-year epidemiological study
por: Zhang, Huimin, et al.
Publicado: (2019)

Pyrotinib for HER2-positive metastatic breast cancer: a systematic review and meta-analysis
por: Hu, Wenyu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r958si90n4ig9cq39s73svqlu1